Cover Image
市場調查報告書

動物、家畜用疫苗的全球市場的預測 ∼2022年:豬微小病毒病,豬隻流行性肺炎,禽流感,狂犬病(恐水症),梭狀芽胞桿菌感染

Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 281737
出版日期 內容資訊 英文 158 Pages
訂單完成後即時交付
價格
Back to Top
動物、家畜用疫苗的全球市場的預測 ∼2022年:豬微小病毒病,豬隻流行性肺炎,禽流感,狂犬病(恐水症),梭狀芽胞桿菌感染 Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology - Global Forecast to 2022
出版日期: 2017年11月02日 內容資訊: 英文 158 Pages
簡介

全球動物、家畜用疫苗市場,預計從2017年到2022年以5.9%的年複合成長率(CAGR)發展,2017年擴大到65億美元,2022年達86億6000萬美元規模。家畜數的增加與重複的傳染病發生,寵物受歡迎,人畜共通傳染病的發病率上升,相關機關的舉措的整備,新型疫苗的引進等要素促進這個市場成長。

本報告提供全球動物、家畜用疫苗市場調查,市場及產品概要,市場成長的各種影響要素與市場機會分析,各類型、疾病、技術、地區的趨勢,市場規模的變化與預測,競爭環境,主要企業簡介等,總括性彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 動物、家畜用疫苗市場概要
  • 亞太地區的動物、家畜用疫苗市場:各技術、地區
  • 家禽用疫苗市場:各疾病
  • 動物、家畜用疫苗市場:各地區

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
      • 家畜數的增加和傳染病重複發生
      • 寵物的普及
      • 人畜共通傳染病的發病率增加
      • 新型疫苗的引進
    • 阻礙因素
      • 疫苗的保管成本
    • 機會
      • 技術發展
      • 在新興經濟國對動物、家畜健康的意識高漲
    • 課題
      • 不完全的傳染病監視、報告系統

第6章 動物、家畜用疫苗的全球市場:各類型

  • 簡介
  • 豬隻用疫苗
  • 家禽用疫苗
  • 家畜用疫苗
    • 牛用疫苗
    • 小型反芻動物用疫苗
  • 寵物用疫苗
    • 狗用疫苗
    • 貓用疫苗
  • 水產養殖動物用疫苗
  • 其他

第7章 動物、家畜用疫苗的全球市場:各疾病

  • 簡介
  • 豬隻
  • 家禽
  • 家畜
    • 小型反芻動物
  • 寵物
  • 水產養殖動物
  • 其他

第8章 動物、家畜用疫苗的全球市場:各技術

  • 簡介
  • 弱毒化活病毒疫苗 (LAV)
  • 不活化疫苗
  • 類毒素疫苗
  • 重組的疫苗
  • 其他

第9章 動物、家畜用疫苗的全球市場:各地區

  • 簡介
  • 歐洲
  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 泰國
    • 印度
    • 其他
  • 其他地區

第10章 競爭環境

  • 市場排行榜分析

第11章 企業簡介

  • 簡介
  • ZOETIS
  • MERCK ANIMAL HEALTH
  • BOEHRINGER INGELHEIM
  • ELANCO
  • CEVA
  • VIRBAC
  • VETOQUINOL
  • PHIBRO ANIMAL HEALTH
  • HESTER
  • HIPRA
  • IDT BIOLOGIKA
  • BIOGENESIS BAGO
  • TIANJIN RINGPU
  • CHINA ANIMAL HUSBANDRY
  • JINYU BIO-TECHNOLOGY

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PH 3475

"Veterinary Vaccines market is projected to register a CAGR of 5.9%"

The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. On the other hand, the high storage cost for vaccines is expected to restrain the market to a certain extent.

"The companion animal vaccines segment is expected to grow at the highest rate during the forecast period"

On the basis of type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other vaccines. The companion animal vaccines segment is divided into canine vaccines and feline vaccines and in terms of value, the companion animal vaccines segment is expected grow at the highest CAGR during the forecast period. Increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets and increasing pet ownership are fueling the demand for these vaccines.

"The live attenuated vaccines segment is expected to account for the largest share of the market in 2017"

By technology, the market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines. In terms of value, the live attenuated vaccines segment is expected to account for the largest share of the market in 2017. The ease of administration and long-term immunity offered by the live attenuated vaccine technologies are driving the demand for this segment in the veterinary vaccines industry.

"Asia Pacific to provide significant growth opportunities during the forecast period"

Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in the region, and the wide range of product launches and investments in veterinary vaccines manufacturing facilities in the region, especially in India, China, and Thailand.

Break-up Profile of Primaries:

  • By Company Type- Tier 1-40%, Tier 2-35% and Tier 3-25%
  • By Designation-C-level-33%, D-level-41% and Others-26%
  • By Region-North America-35%, Europe-30%, Asia-21%, and RoW-14%

The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).

Research Coverage:

The veterinary vaccines market in this report is segmented by type, disease, technology, and region. The study tracks and analyzes competitive developments such as product launches; expansions; agreements, partnerships, and collaborations; and acquisitions. It also profiles the key players and their core competencies within the veterinary vaccines market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global veterinary vaccines market. The report analyzes the veterinary vaccines market by type, disease, technology, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the veterinary vaccines market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for veterinary vaccines across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global veterinary vaccines market
  • Competitive Assessment: In-depth assessment of, strategies, products, and manufacturing capabilities of the key players in the global veterinary vaccines market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primary interviews
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.3.1. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL VETERINARY VACCINES MARKET OVERVIEW
  • 4.2. APAC VETERINARY VACCINES MARKET, BY TECHNOLOGY AND REGION
  • 4.3. POULTRY VETERINARY VACCINES MARKET, BY DISEASE
  • 4.4. VETERINARY VACCINES MARKET, BY GEOGRAPHY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growth in livestock population and repeated outbreaks of livestock diseases
      • 5.2.1.2. Increasing adoption of companion animals
      • 5.2.1.3. Rising incidence of zoonotic diseases
      • 5.2.1.4. Initiatives by various government agencies, animal associations, and leading players
      • 5.2.1.5. Introduction of new types of vaccines
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High storage costs for vaccines
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Technological advancements
      • 5.2.3.2. Growing awareness of animal health in emerging economies
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Inadequate surveillance and reporting systems

6. VETERINARY VACCINES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. PORCINE VACCINES
  • 6.3. POULTRY VACCINES
  • 6.4. LIVESTOCK VACCINES
    • 6.4.1. BOVINE VACCINES
    • 6.4.2. SMALL RUMINANT VACCINES
  • 6.5. COMPANION ANIMAL VACCINES
    • 6.5.1. CANINE VACCINES
    • 6.5.2. FELINE VACCINES
  • 6.6. AQUACULTURE VACCINES
  • 6.7. OTHER ANIMAL VACCINES

7. VETERINARY VACCINES MARKET, BY DISEASE

  • 7.1. INTRODUCTION
  • 7.2. PORCINE
  • 7.3. POULTRY
  • 7.4. LIVESTOCK
    • 7.4.1. BOVINE
    • 7.4.2. SMALL RUMINANTS
  • 7.5. COMPANION ANIMALS
    • 7.5.1. CANINE
    • 7.5.2. FELINE
  • 7.6. AQUACULTURE

8. VETERINARY VACCINES MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. LIVE ATTENUATED VACCINES
  • 8.3. INACTIVATED VACCINES
  • 8.4. TOXOID VACCINES
  • 8.5. RECOMBINANT VACCINES
  • 8.6. OTHER VACCINES

9. VETERINARY VACCINES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. EUROPE
  • 9.3. NORTH AMERICA
    • 9.3.1. US
    • 9.3.2. CANADA
  • 9.4. ASIA PACIFIC (APAC)
    • 9.4.1. CHINA
    • 9.4.2. THAILAND
    • 9.4.3. INDIA
    • 9.4.4. REST OF APAC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET RANKING ANALYSIS

11. COMPANY PROFILES (BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

  • 11.1. ZOETIS
  • 11.2. MERCK ANIMAL HEALTH
  • 11.3. BOEHRINGER INGELHEIM
  • 11.4. ELANCO
  • 11.5. CEVA
  • 11.6. VIRBAC
  • 11.7. VETOQUINOL
  • 11.8. PHIBRO ANIMAL HEALTH
  • 11.9. HESTER
  • 11.10. HIPRA
  • 11.11. IDT BIOLOGIKA
  • 11.12. BIOGENESIS BAGO
  • 11.13. TIANJIN RINGPU
  • 11.14. CHINA ANIMAL HUSBANDRY
  • 11.15. JINYU BIO-TECHNOLOGY

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL LIVESTOCK ANIMAL POPULATION, 2000 AND 2013
  • TABLE 2: ANIMAL DISEASE OUTBREAKS REPORTED IN RECENT YEARS
  • TABLE 3: PERCENTAGE OF PET OWNERSHIP, BY COUNTRY, 2016
  • TABLE 4: SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 (MILLION)
  • TABLE 5: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: PORCINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: POULTRY VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: LIVESTOCK VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 16: BOVINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: SMALL RUMINANT VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: COMPANION ANIMAL VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 26: CANINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: FELINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: AQUACULTURE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: OTHER ANIMAL VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 37: PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: ASIA PACIFIC: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 47: INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 50: AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 56: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 57: FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 58: BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 59: BOVINE CLOSTRIDIAL DISEASE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 60: BRUCELLOSIS VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 61: SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 62: CANINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 63: FELINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 64: AQUACULTURE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 65: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 66: LIVE ATTENUATED VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 67: NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 68: ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 69: INACTIVATED VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 70: NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 72: TOXOID VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 73: NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 75: RECOMBINANT VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 76: NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 77: ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 78: OTHER VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 79: NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 80: ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 81: VETERINARY VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 82: EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 86: EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 87: EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 88: EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 89: NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 90: NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 93: NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 94: NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 95: NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 96: NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 97: US: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: US: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 99: US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: US: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 101: US: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 102: US: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 103: CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 106: CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 107: CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 108: CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 109: ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 110: ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 111: ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 113: ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 114: ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 115: ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 116: ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 117: CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 120: CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 121: CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 122: CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 123: THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 126: THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 127: THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 128: THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 129: INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 130: INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 131: INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 132: INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 133: INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 134: INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 135: ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 136: ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 137: ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 138: ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 139: ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 140: ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 141: ROW: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 142: ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 143: ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: ROW: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 145: ROW: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 146: ROW: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 147: ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 148: RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: VETERINARY VACCINES MARKET
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: VETERINARY VACCINES MARKET, BY TYPE, 2017 VS. 2022
  • FIGURE 7: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017 VS. 2022
  • FIGURE 8: PORCINE VACCINES MARKET, BY DISEASE, 2017 VS. 2022
  • FIGURE 9: VETERINARY VACCINES MARKET, BY REGION
  • FIGURE 10: GROWTH IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES ARE DRIVING THE VETERINARY VACCINES MARKET
  • FIGURE 11: LIVE ATTENUATED VACCINES SEGMENT IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 12: INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 AND 2022
  • FIGURE 13: APAC IS EXPECTED TO HAVE THE FASTEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: PORCINE VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2017
  • FIGURE 16: LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2022
  • FIGURE 17: GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 18: EUROPE: VETERINARY VACCINES MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT
  • FIGURE 20: ZOETIS: COMPANY SNAPSHOT (2016)
  • FIGURE 21: MERCK & CO. INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 22: BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016)
  • FIGURE 23: ELANCO: COMPANY SNAPSHOT (2016)
  • FIGURE 24: CEVA: COMPANY SNAPSHOT (2016)
  • FIGURE 25: VIRBAC: COMPANY SNAPSHOT (2016)
Back to Top